Abstract
Toll-like receptor 9 activation enhances B cell activating factor and interleukin-21 induced anti-proteinase 3 autoantibody production in vitro 
Introduction
Granulomatosis with polyangiitis (GPA) is characterised by necrotising inflammation of the small-to medium-sized blood vessels, frequently affecting the respiratory tract and kidneys [1] . A hallmark of GPA is the presence of circulating anti-neutrophil cytoplasmic autoantibodies (ANCA), which are mainly directed against proteinase 3 (PR3) [1, 2] . In patients, a rising serum titer of PR3-ANCA often precedes a disease relapse, supporting the notion that autoantibodies are involved in disease pathogenesis. The pathogenic potential of PR3-ANCA has been studied both in vitro and in vivo (reviewed by Land et al. [3] ). Neutrophil and monocyte stimulation in vitro with PR3-ANCA induces cell activation, resulting in generation of reactive oxygen species, neutrophil degranulation and proinflammatory cytokine production [4] [5] [6] [7] . More recently, experiments in humanised mice demonstrated that PR3-ANCA can induce acute vascular injury, providing further support for a direct pathogenic role of these autoantibodies [8] .
Although the pathogenic potential of PR3-ANCA is well established, the mechanisms that trigger PR3-ANCA production and disease relapse are less clear. Based on clinical observations, infections have been proposed to play an important role in GPA pathogenesis. In GPA patients, chronic nasal carriage of Staphylococcus aureus is strongly linked to relapsing disease, and maintenance treatment with the antibiotic co-trimoxazole can prevent relapses [9, 10] . The association with infections is further supported by in vitro studies demonstrating that B cell stimulation with Toll-like receptor (TLR) 9 ligand oligodeoxynucleotides containing CpG motifs (CpG-ODN) can induce the production of PR3-ANCA [11, 12] .
Given that ANCA predominantly belong to IgG1 and IgG4 subclasses, this suggests that an antigen-driven T cell-dependent immune response mediates ANCA production [13, 14] . In particular, a specific T-helper cell subset characterised by production of interleukin (IL)-21 provides signals to B cells, supporting generation of high-affinity clones and differentiation to plasma cells [15] . We have recently reported increased frequencies of IL-21-producing CD4+ T-helper cells in the circulation of GPA patients during remission [16] . IL-21 signalling is environment dependent, and co-stimulatory signals have a critical influence on the resultant biological effect. In combination with CD40 signalling, IL-21 stimulates naive B cell proliferation and differentiation, whereas together with B cell activating factor (BAFF), IL-21 can stimulate plasma cell formation and antibody production by antigen-experienced B cells [17, 18] . BAFF is crucial for B cell survival, proliferation and differentiation, and overexpression of BAFF is strongly associated with the development of systemic autoimmunity [19] . Increased BAFF levels have been reported in patients with various autoimmune disorders, including systemic lupus erythematosus (SLE) and Sjogren's syndrome (SS), as well as GPA [20] [21] [22] [23] .
The observations that in GPA the proportion of IL-21+ helper T cells is increased and that BAFF concentrations are elevated even during clinical remission suggest that in these patients an environment exists that facilitates survival and activation of 3 PR3-ANCA PRoduCtioN in vitro autoreactive B cells. As the relapsing nature of GPA has been associated with infections, we hypothesised that infectious agents can synergise with BAFF and IL-21 present in the endogenous environment to stimulate autoantibody production in GPA patients.
To test this hypothesis, we studied the effect of IL-21, BAFF and the TLR9 agonist CpG-ODN on PR3-ANCA production, B cell proliferation and plasma cell formation.
Furthermore, we evaluated the expression of receptors for IL-21 and BAFF on circulating B cells and studied the effect of CpG-ODN stimulation on the expression of these receptors in GPA patients and healthy controls (HCs).
Patients and Methods

Study population
Patient and HC characteristics are described in [24, 25] . Samples were obtained in compliance with the Declaration of Helsinki.
All subjects provided informed consent, and the study was approved by the Medical Ethics Committee of the University Medical Center Groningen, University of Groningen (the Netherlands).
Peripheral blood mononuclear cell isolation and culture
Peripheral blood mononuclear cells (PBMCs) were isolated from heparinised blood as described before [12] . Cells were cultured at a concentration of 1 x 10 6 cells/mL in the presence of 100 ng/mL BAFF (PeproTech Inc., Rocky Hill, NJ, USA), 100 ng/mL IL-21
(Immunotools, Friesoythe, Germany), 3.2 μg/mL CpG-ODN 2006 (Hycult Biotech, Uden, the Netherlands) and combinations at 37°C with 5% CO 2 (as previously described [11, 12] ). After 12 days of stimulation, the culture supernatants were collected and stored at -20 °C. 
Quantification of PR3-ANCA
Plasma cell formation
Freshly isolated PBMCs from HCs were suspended in culture medium at a concentration of 10 6 cells/mL and treated with 3.2 µg/mL CpG-ODN, 100 ng/mL BAFF, 100 ng/mL IL-21, combinations of the stimuli, or were left without stimulation. After 7 days, the cells were harvested, washed and labelled with anti-human CD19-eFluor-450, anti-human CD22-PE-Cy5, anti-human CD27-APC-eFluor-780 (eBioscience), and anti-human CD38-PE-Cy7 (eBioscience). After washing, the cells were measured using a BD LSR-II flow cytometer. The data were analysed using Kaluza 1.2 Flow Analysis Software (Beckman Coulter, Brea, CA, USA), and cells with a CD19+CD27 high CD38 high phenotype were considered plasma cells.
Characterisation of IL-21R, BAFF-R and TACI expression of B cell subsets by flow cytometry
Freshly drawn EDTA blood was washed twice with PBS and 1% BSA, and 100 µl of the cell suspension was incubated with anti-human CD19-PerCP, anti-human CD27-FITC, anti-human CD38-APC (all from BD Biosciences), and either anti-human IL-21R-PE (BD Biosciences), anti-human BAFF-R-PE (BioLegend, San Diego, CA, USA), anti-human TACI-PE (BioLegend), or the corresponding isotype control antibodies for 15 minutes.
Erythrocytes were lysed with FACS Lysing Solution. Cells were washed and analysed with a FACSCalibur. The data were analysed using Kaluza 1.2 Flow Analysis Software.
Alternatively, freshly isolated PBMCs were suspended to a concentration of 10 6 cells/ mL. Some of the cells were used directly for staining to measure the baseline expression of IL-21R, BAFF-R and TACI. Cells were stimulated with CpG-ODN (3.2 μg/mL) for 4 or 24 h. At the end of the experiment, cells were washed with PBS plus 5% fetal calf serum. Then cells were stained for surface expression of IL-21R, BAFF-R and TACI using the staining protocol described above for the whole blood samples. To investigate whether in vitro ANCA production was related to the PR3-ANCA serum level, we measured PR3-ANCA levels in serum samples from the corresponding patients collected at the time of cell isolation. A significant positive correlation was found between PR3-ANCA serum levels and the amount of PR3-ANCA produced in vitro ( Figure 1F ).
As non-specific systemic inflammation in GPA patients could affect the autoantibody levels measured in serum or in culture supernatants, we tested whether PR3-ANCA levels were associated with C reactive protein (CRP) or creatinine concentrations in serum. There was no significant correlation between the serum or in vitro levels of PR3-ANCA and CRP or creatinine (supplementary Figure 2) .
CpG-ODN, BAFF and IL-21 induce B cell proliferation and plasma cell formation
CpG-ODN is known to promote formation of plasma blasts [26] and, together with BAFF, it induces B cell activation, proliferation, and immunoglobulin secretion [27, 28] . 
CpG-ODN up-regulates IL-21R and TACI, but not BAFF-R expression on B cells
As the combined treatment with BAFF, IL-21 and CpG-ODN was a more potent inducer of PR3-ANCA production compared with BAFF and IL-21, we questioned whether stimulation with CpG-ODN sensitises B cells for stimulation with IL-21 and BAFF. To this end, we evaluated the effect of CpG-ODN on the expression of the receptors for IL-21 and BAFF. IL-21 signals through IL-21R, which is mainly expressed on transitional and naive B cells, and to a lesser extent on memory B cells [17] . BAFF is known to signal through three receptors, namely BAFF-R, TACI, and B cell maturation antigen. As B cell maturation antigen is mainly expressed on terminally differentiated plasma cells and is almost absent on B cells [18, 29] , we only studied the expression of BAFF-R and TACI, which are abundantly expressed on B cells. 
Altered IL-21R and TACI expression on naive and memory B cells and decreased BAFF-R expression in GPA patients
We evaluated the expression of IL-21R, TACI and BAFF-R on total B cells and on naive and memory B cell subsets in HCs and GPA patients. As reported previously [16] , the median percentage of IL-21R+ B cells was comparable between HCs and patients (71.6% and 73.5% in HCs and GPA patients, respectively). However, when subdivided p=0.0050; Figure 4A ). Figure 4B ).
Finally, we assessed BAFF-R expression on B cells. Although BAFF-R expression levels were highly variable in both HCs and GPA patients (MFI range 14.4-76.5 in HCs and 0.5-52.7 in GPA patients), the median expression level of BAFF-R on B cells in GPA patients was significantly lower when compared with HCs (p=0.0113; Figure 4C ).
Previous studies have reported internalisation of BAFF-R upon binding to its ligand, and circulating BAFF levels were shown to be inversely correlated with BAFF-R expression on peripheral lymphocytes [30] . Given that GPA patients have elevated levels of circulating BAFF [22, 23, 31] , we hypothesised that the decreased BAFF-R expression is related to the increased circulating BAFF levels. Therefore, we measured circulating BAFF levels in plasma of patients and correlated it with the BAFF-R level on B cells. We found a significant negative correlation between the level of circulating BAFF and the level of BAFF-R expressed on the peripheral B cells (Spearman's r=-0.6431, p=0.0017; Figure 4D ). In GPA patients, the expression levels of IL-21R, TACI and BAFF-R on B cells were not correlated with the serum concentrations of CRP or creatinine, indicating that the alterations in the receptor expression are not associated with a non-specific inflammatory response (supplementary Figure 3) .
Discussion
In GPA pathogenesis, ANCA are considered pivotal mediators of the vasculitic damage.
In the present study, we studied factors potentially involved in the production of PR3-ANCA. Here, we show that the TLR9 agonist CpG-ODN, together with BAFF and IL-21, enhances the production of PR3-ANCA, demonstrating that both endogenous and exogenous factors are effectively involved in (auto)antibody production in GPA patients.
We confirm the previously reported effect of CpG-ODN on B cell proliferation [32] [33] [34] and show that this effect can be enhanced further by addition of BAFF and IL-21. The to the development of a lupus-like condition, whereas blockade of these cytokines ameliorates the disease severity [19, 41] . Hence, BAFF, IL-21 and/or their receptors are considered potential therapeutic targets for treatment of autoimmune disorders.
A monoclonal antibody inhibiting BAFF has been approved for the treatment of SLE patients [42] , and ongoing clinical trials also aim to test the efficacy of anti-BAFF therapy in vasculitis patients [43] . As the level of circulating BAFF is known to increase after B cell depletion therapy [44] , which is also being used in GPA patients [45] treatment that regulates BAFF levels in the circulation might be useful to prevent aberrant activation of newly formed B cells. More recently, a monoclonal antibody against IL-21 has been developed and is being tested as a possible treatment for RA
[46].
Our study also demonstrates that exogenous factors, such as the TLR9 agonist CpG-ODN enhance the effects of BAFF and IL-21. This is of particular interest when considering that the majority of ANCA-associated vasculitis (AAV) patients are chronic carriers of S. aureus [9] , and staphylococcal DNA is also recognised by TLR9 [47] .
Interestingly, some drugs, such as hydroxychloroquine, work through inhibition of TLR9 signalling and are used in autoimmune disorders, mainly SLE [48] . Treatment improves patient survival and remission rates, as well as reducing disease activity [49] . Reduction 54 of infectious agents in patients may be equally effective, and antibiotic treatments have been shown to reduce the risk for relapse in GPA [10] . The data of the present study provide additional evidence that blockade of TLR9, BAFF and/or IL-21 might be beneficial strategies for amelioration of autoantibody-mediated diseases.
Our study primarily focused on patients in clinical remission and only a limited number of patients with active disease (n=6) were included to establish ANCA production in vitro. Also, owing to limited access to material from patients with active disease, the expression of IL-21R, BAFF-R and TACI was characterised only in patients during clinical remission. Additional studies are needed to elucidate whether the expression of these receptors is affected by disease activity.
Another limitation of our study is that experiments were performed on lymphocytes derived from peripheral blood, whereas the generation and activation of ANCAspecific autoreactive B cells is most likely to occur in secondary lymphoid organs or tertiary lymphoid structures in the affected organs. Nevertheless, it is intriguing that ANCA-specific lymphocytes can be found in the circulation of GPA patients in clinical remission, which suggests ongoing generation of ANCA-specific B cells even during quiescent disease. As ANCA have a major role in the effector phase of GPA [2] , the factors that contribute to the production of autoantibodies potentially could exacerbate disease activity or promote the occurrence of relapses. Currently, we are performing a prospective study to test whether in vitro ANCA production could serve as a predictor of relapse in AAV patients.
In conclusion, we have demonstrated that endogenous B cell stimuli and bacterial products can contribute to PR3-specific B cell activation in GPA patients in remission, emphasising the contribution of infectious agents in reactivation of autoantibody production. Therapeutic strategies that regulate B cell activation might be useful to sustain stable remission in GPA patients.
Key Messages
-Granulomatosis with polyangiitis patients have PR3-specific B cells in circulation even during clinical remission.
-PR3-specific B cells in granulomatosis with polyangiitis patients can be reactivated in vitro by endogenous and exogenous signals. 
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